2023 Annual Report Commemorates 50 Years of Breakthrough Research
BrightFocus Foundation’s 2023 annual report highlights five decades of funding the boldest research and what-if ideas to get us closer to cures for Alzheimer’s disease, macular degeneration, and glaucoma. Donor-supported research has resulted in some of the most powerful novel treatments, advancements, and diagnostic tools in use today.
The eye is the window to the brain, and BrightFocus Foundation is at the forefront of advancing eye and brain research through its unique focus on these three neurodegenerative diseases affecting more than 300 million people worldwide.
BrightFocus also raises awareness and empowers people with these diseases and their loved ones by sharing expert resources and information, including live and on-demand audio and video expert information resources, brochures, and community events and film screenings.
Learn more about our impact over the past year, including:
Remarkable discoveries from our grantees across eye and brain research.
Inspiring stories of donors whose generosity makes this work possible.
About BrightFocus Foundation
BrightFocus Foundation is a premier global nonprofit funder of research to defeat Alzheimer’s, macular degeneration, and glaucoma. Through its flagship programs —Alzheimer's Disease Research, Macular Degeneration Research, and National Glaucoma Research — the Foundation has awarded nearly $290 million in groundbreaking research funding to 6,240 scientists over the past 50 years.
In 2023, BrightFocus awarded 65 new research grants to promising researchers seeking novel treatments and breakthroughs for these diseases of mind and sight. These new grantees join the Foundation’s global portfolio of 276 active projects across 16 countries, 31 U.S. states, and 174 institutions worldwide.
BrightFocus shares the latest research findings, expert information, and resources to empower the millions impacted by these devastating diseases. Learn more at brightfocus.org.